- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/728 - Hyaluronic acid
Patent holdings for IPC class A61K 31/728
Total number of patents in this class: 1948
10-year publication summary
156
|
145
|
170
|
184
|
183
|
185
|
198
|
150
|
141
|
54
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Fidia Farmaceutici S.p.A. | 647 |
50 |
Seikagaku Corporation | 192 |
42 |
Allergan Industrie SAS | 93 |
22 |
The Regents of the University of California | 18943 |
21 |
Allergan, Inc. | 2600 |
20 |
Altergon S.A. | 145 |
20 |
Novartis AG | 11238 |
18 |
University of Utah Research Foundation | 1737 |
18 |
Contipro a.s. | 76 |
16 |
Mayo Foundation for Medical Education and Research | 2981 |
14 |
Aihol Corporation | 27 |
14 |
Buck Institute for Research on Aging | 122 |
14 |
MERZ PHARMA GmbH & CO. KGaA | 624 |
14 |
Teoxane | 40 |
14 |
Unity Biotechnology, Inc. | 76 |
14 |
U.S. Nutraceuticals, L.L.C., DBA Valensa International | 30 |
13 |
Sofar Swiss SA | 44 |
13 |
The Johns Hopkins University | 5377 |
12 |
Laboratoires Vivacy | 66 |
12 |
Galderma Holding S.A. | 711 |
12 |
Other owners | 1575 |